Identification
Listing sponsor / Agent

<p>
EUROLAND FINANCE</p>

Symbol
XXXXX
ISIN code
FR0011005933
Exchange / Market
Euronext
Trading location
Paris
Products family
Stocks
Market organization
Alternext
ICB
Medical Supplies
Activity description

<p>
<strong>Biosyne</strong>x mission is to supply professionals (clinical labs, physicians) with innovative rapid diagnostic kits that enable them to get rapid information in order to improve patients monitoring in both resource-limited settings and advanced medical services.<br />
Biosynex is currently focusing its expertise in four areas where Point of Care testing (POC) will take a growing place in the coming years in an attempt to reduce healthcare costs and bring flexibility to healthcare professionals:</p>
<ul>
<li>
Tropical diseases</li>
<li>
Emergency markers</li>
<li>
Infectious diseases</li>
<li>
Autoimmunity</li>
</ul>
<p>
Fifteen employees are currently working in the company including 5 scientists in R&amp;D department.</p>

Issuer website
http://biosynex.nexenservices.com
Operation
IPO date
IPO type

<p>
Public offer NYSE Alternext &agrave; Paris</p>

IPO type
Initial Public offering
Catégorie
IPO